Shirish N. Raja
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shirish N. Raja has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Bruce W. Surber
Process Chemistry Department, R450, AP9, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6114, U.S.A.
1 shared publicationJeffrey L. Cross
Structural Chemistry, R418, AP9, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6114, U.S.A.
1 shared publicationJia Du
Process Chemistry Department, R450, AP9, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6114, U.S.A.
1 shared publication
Latest Publications
- 8 January 2009
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 52 (3) , 98-102
Synthesis of [3H]ABT‐518, a matrix metalloproteinase inhibitor (MMPI) labeled in the phenyl rings
A novel matrix metalloproteinase inhibitor, ABT‐518, [S‐(R*, R*)]‐N‐[1‐(2, 2‐dimethyl‐1,3‐dioxol‐4‐yl)‐2‐[[4‐[4‐(trifluoromethoxy)‐phenoxy]phenyl]sulfonyl]ethyl]‐N‐hydroxyformamide, was labeled with tritium in two phenyl rings in a seven‐step synthesis. The overall radiochemical yield of [3H]ABT‐518 in seven steps starting from 1‐(methylsulfonyl)‐4‐[4‐(trifluoromethoxy)phenoxy]benzene was 6.2% with the radiochemical purity of 99.4%. Copyright © 2009 John Wiley & Sons, Ltd.
- 8 January 2009
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 52 (3) , 98-102
Synthesis of [3H]ABT‐518, a matrix metalloproteinase inhibitor (MMPI) labeled in the phenyl rings
A novel matrix metalloproteinase inhibitor, ABT‐518, [S‐(R*, R*)]‐N‐[1‐(2, 2‐dimethyl‐1,3‐dioxol‐4‐yl)‐2‐[[4‐[4‐(trifluoromethoxy)‐phenoxy]phenyl]sulfonyl]ethyl]‐N‐hydroxyformamide, was labeled with tritium in two phenyl rings in a seven‐step synthesis. The overall radiochemical yield of [3H]ABT‐518 in seven steps starting from 1‐(methylsulfonyl)‐4‐[4‐(trifluoromethoxy)phenoxy]benzene was 6.2% with the radiochemical purity of 99.4%. Copyright © 2009 John Wiley & Sons, Ltd.
- 24 June 2003
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 46 (9) , 883-892
Synthesis of [14C]ABT‐770, matrix metalloproteinase inhibitor (MMPI), labelled in the phenoxy ring
The MMPI [14C]ABT‐770 (1), N‐[(1S)‐1‐[(4,4‐Dimethyl‐2,5‐dioxo‐1‐imi‐dazolidinyl)methyl]]‐2‐[[4′‐(trifluoromethoxy)[1,1′‐biphenyl]‐4‐yl]oxy]ethyl]‐N‐hydroxyformamide was synthesized in 8 steps using 4‐bromophenol‐UL‐14C (10) as a starting material. The Carbon‐14 label was introduced in one of the metabolically stable biphenyl rings. The key sequence of the synthesis was a three‐step one‐pot reaction in which the hydantoin moiety was introduced, the imine oxidized and further hydrolyzed to get the penultimate precursor to [14C]ABT‐770 (1) in 56% yield. Copyright © 2003 John Wiley & Sons, Ltd.
- 24 June 2003
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 46 (9) , 883-892
Synthesis of [14C]ABT‐770, matrix metalloproteinase inhibitor (MMPI), labelled in the phenoxy ring
The MMPI [14C]ABT‐770 (1), N‐[(1S)‐1‐[(4,4‐Dimethyl‐2,5‐dioxo‐1‐imi‐dazolidinyl)methyl]]‐2‐[[4′‐(trifluoromethoxy)[1,1′‐biphenyl]‐4‐yl]oxy]ethyl]‐N‐hydroxyformamide was synthesized in 8 steps using 4‐bromophenol‐UL‐14C (10) as a starting material. The Carbon‐14 label was introduced in one of the metabolically stable biphenyl rings. The key sequence of the synthesis was a three‐step one‐pot reaction in which the hydantoin moiety was introduced, the imine oxidized and further hydrolyzed to get the penultimate precursor to [14C]ABT‐770 (1) in 56% yield. Copyright © 2003 John Wiley & Sons, Ltd.